Phathom Pharmaceuticals, Inc. (PHAT)

Phathom Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	297.26	381.39	155.39	183.26	287.5
Cash & Short-Term Investments	297.26	381.39	155.39	183.26	287.5
Cash Growth	-22.06%	145.45%	-15.21%	-36.26%	17.94%
Receivables	38.8	1.64	-	-	-
Inventory	3.21	1.21	-	-	-
Prepaid Expenses	20.87	13.19	5.13	3.27	3.87
Total Current Assets	360.13	397.43	160.51	186.53	291.37
Property, Plant & Equipment	2.09	3.62	3.49	2.56	3.36
Other Long-Term Assets	16.1	12.79	0.8	0.34	0.38
Total Assets	378.32	413.84	164.81	189.43	295.11
Accounts Payable	10.51	12.6	10	5.15	16.78
Accrued Expenses	54.94	18.34	15.53	13.28	30.92
Current Portion of Long-Term Debt	19.78	7.11	-	-	7.35
Current Portion of Leases	0.5	0.73	0.71	0.49	0.47
Total Current Liabilities	85.73	38.78	26.24	18.92	55.52
Long-Term Debt	534.67	437.66	204.79	89.67	39.63
Long-Term Leases	-	0.46	1.1	1.18	1.56
Other Long-Term Liabilities	11.5	9.7	7.5	7.5	4.13
Total Liabilities	631.9	486.6	239.62	117.28	100.84
Common Stock	0.01	0.01	0	0	0
Additional Paid-In Capital	1,009	855.92	652.28	601.52	579.76
Retained Earnings	-1,263	-928.69	-727.09	-529.37	-385.49
Shareholders' Equity	-253.58	-72.76	-74.81	72.16	194.27
Total Liabilities & Equity	378.32	413.84	164.81	189.43	295.11
Total Debt	554.95	445.96	206.6	91.34	49.02
Net Cash (Debt)	-257.69	-64.56	-51.21	91.92	238.48
Net Cash Growth	-	-	-	-61.46%	8.30%
Net Cash Per Share	-4.08	-1.26	-1.31	2.48	7.18
Filing Date Shares Outstanding	69.64	58.48	41.72	30.57	28.57
Total Common Shares Outstanding	68.52	57.97	41.47	30.51	28.52
Working Capital	274.41	358.65	134.28	167.61	235.84
Book Value Per Share	-3.70	-1.26	-1.80	2.36	6.81
Tangible Book Value	-253.58	-72.76	-74.81	72.16	194.27
Tangible Book Value Per Share	-3.70	-1.26	-1.80	2.36	6.81
Machinery	4.16	4.05	2.16	1.43	1.26
Construction In Progress	-	-	0.4	-	-
Leasehold Improvements	0.16	0.14	0.12	0.08	0.05

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q